Literature DB >> 23276979

Genetics of familial and sporadic Alzheimer's disease.

Irene Piaceri1, Benedetta Nacmias, Sandro Sorbi.   

Abstract

Alzheimer's disease (AD) is an age-related progressive neurodegenerative disorder. A majority of cases manifest as a late onset sporadic form but genetically the disease is divided into familial cases and sporadic cases. The familial form is due to mutations in three major genes (amyloid precursor protein (APP) gene, presenilin1 (PSEN1) gene and presenilin 2 (PSEN2) gene). In contrast, many genetic and environmental factors may contribute to determining the sporadic AD form. Despite many years of research and great progress in the knowledge of the molecular pathogenesis of AD, a full understanding of the etiology of the sporadic form is still not yet in reach. Genome-wide association studies (GWASs) revealed the genetic complexity of the disease and recent studies suggested that epigenetic mechanisms may play an essential role in disease development. This review provides an overview of all the milestones in AD genetic research, as well as the new and promising approach, in order to better understand the genetic profile for predicting the risk of AD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23276979     DOI: 10.2741/e605

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  63 in total

Review 1.  Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.

Authors:  Cátia Janota; Cynthia A Lemere; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2015-07-05       Impact factor: 5.590

2.  The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-β production and Tau hyperphosphorylation.

Authors:  Daniel Paris; Ghania Ait-Ghezala; Corbin Bachmeier; Gary Laco; David Beaulieu-Abdelahad; Yong Lin; Chao Jin; Fiona Crawford; Michael Mullan
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

Review 3.  Imaging markers of structural and functional brain changes that precede cognitive symptoms in risk for Alzheimer's disease.

Authors:  Alison Burggren; Jesse Brown
Journal:  Brain Imaging Behav       Date:  2014-06       Impact factor: 3.978

4.  Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex.

Authors:  Douglas G Walker; Alexis M Whetzel; Geidy Serrano; Lucia I Sue; Thomas G Beach; Lih-Fen Lue
Journal:  Neurobiol Aging       Date:  2014-10-02       Impact factor: 4.673

5.  Rab21, a Novel PS1 Interactor, Regulates γ-Secretase Activity via PS1 Subcellular Distribution.

Authors:  Zhenzhen Sun; Yujie Xie; Yintong Chen; Qinghu Yang; Zhenzhen Quan; Rongji Dai; Hong Qing
Journal:  Mol Neurobiol       Date:  2017-05-25       Impact factor: 5.590

6.  KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease.

Authors:  Mengni Yi; Panpan Yu; Qin Lu; Herbert M Geller; Zhihua Yu; Hongzhuan Chen
Journal:  Mol Cell Neurosci       Date:  2016-08-24       Impact factor: 4.314

Review 7.  The Role of PGRN in Alzheimer's Disease.

Authors:  Hua Jing; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2015-07-28       Impact factor: 5.590

Review 8.  Utility and validity of DISC1 mouse models in biological psychiatry.

Authors:  T Tomoda; A Sumitomo; H Jaaro-Peled; A Sawa
Journal:  Neuroscience       Date:  2016-01-06       Impact factor: 3.590

9.  Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes.

Authors:  Claudia Olive; Laura Ibanez; Fabiana H Geraldo Farias; Fengxian Wang; John P Budde; Joanne B Norton; Jen Gentsch; John C Morris; Zeran Li; Umber Dube; Jorge Del-Aguila; Kristy Bergmann; Joseph Bradley; Bruno A Benitez; Oscar Harari; Anne Fagan; Beau Ances; Carlos Cruchaga; Maria Victoria Fernandez
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

10.  The Effects of Gene-Environment Interactions Between Cadmium Exposure and Apolipoprotein E4 on Memory in a Mouse Model of Alzheimer's Disease.

Authors:  Liang Zhang; Hao Wang; Glen M Abel; Daniel R Storm; Zhengui Xia
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.